Microbiotica
- Health & Biotech
- Cambridge, GB
- Founded 2016
- Private
- microbiotica.com
Clinical-stage UK biopharma developing oral microbiome medicines; its Series C first close funds a Phase 2 ulcerative colitis trial.
$48MEquity raised in 2025–20262025 — · 2026 $48M · 1 equity round
$48MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Microbiotica was founded in 2016 and raised before 16 Oct 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series C (first close)Amount$48MGBP 36MPost-money—◔ Reported
- Earlier rounds not yet sourced
Investors 6
- British Business Bank1
- Cambridge Innovation Capital
- Flerie Invest
- IP Group
- Seventure Partners
- Tencent
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
CMR SurgicalHealth · $600M in 2025–2026Shared: Tencent, Cambridge Innovation CapitalQuantum MotionDeep Tech · $160M in 2025–2026Shared: British Business Bank, IP GroupSalience LabsAI Infra · $155M in 2025–2026Shared: British Business Bank, Cambridge Innovation CapitalMoonshot AIAI Labs · $6.7B in 2025–2026Shared: TencentWayveRobotics · $1.3B in 2025–2026Shared: British Business BankIneffable IntelligenceAI Labs · $1.1B in 2025–2026Shared: British Business Bank
Also in the Cambridge hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Microbiotica and its logo are trademarks of their owners, used here for identification only.
